| 【Company Research】Weibo (WB US) – Expect mild recovery in 3Q23E |
| 【Company Research】Cloud Music (9899 HK) – 1H23 earnings beat on strong GPM expansion |
| 【Company Research】China Life (2628 HK) – Outpaced VNB growth in 1H23; short-term NP pushback not affect value growth |
| 【Company Research】Sunny Optical (2382 HK) – Expect shipment recovery on track in 2H23E; Maintain Hold on margin overhang |
| 【Company Research】YSB (9885 HK) – Digitalizing outside-of-hospital pharmaceutical circulation market in China |
| 【Company Research】Intron Technology (1760 HK) – 1H23 results below; expect back-loaded in 2H23E |
| 【Company Research】China Tower (788 HK) – 2Q23 results in-line with expectations; cash flow under temporary pressure |
| 【Company Research】ZTE (763 HK) – 1H23 earnings lifted by improved gross margin |
| 【Company Research】Innovent Biologics (1801 HK) – Strong sales growth with improved cost efficiency |
| 【Company Research】Jiumaojiu (9922 HK) – Tai Er’s OPM and Song are the key drivers |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
